AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22047559
Drug: On-demand therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand therapy (AICC at a target dose of 85 U/kg [±15%] used for bleeding episodes)
Trial: 19780298
Drug: Primary cisplatin-based
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Primary cisplatin-based intraperitoneal therapy
Trial: 19780298
Drug: Intravenous cisplatin-based
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisplatin-based treatment
Trial: 10400014
Drug: Acetylsalicylate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylsalicylate (1 g IV) after bradykinin infusion into the iliac artery
Trial: 10400014
Drug: Acetylsalicylate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylsalicylate (1 g IV) after bradykinin infusion into the left coronary artery
Trial: 2100324
Drug: Ranitidine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 50 mg i.v.
Trial: 2100324
Drug: Ranitidine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 50 mg i.v. and metoclopramide, 10 mg i.v.
Trial: 7369098
Drug: Prajmalium bitartrate
RxNorm normalized name: prajmalium bitartrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prajmalium bitartrate (60 mg orally, 20 mg every 4 hours)
Trial: 7369098
Drug: Lidocaine (2.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (2.1 mg/minute infusion, daily dose of 3 g)
Trial: 7369098
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiarrhythmic drug)
Trial: 28202358
Drug: Lipotoxin (onabotulinumtoxinA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipotoxin (onabotulinumtoxinA 200 U with 80 mg sphingomyelin)
Trial: 22131602
Drug: Home-based evaluation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based evaluation and treatment of OSA
Trial: 22131602
Drug: Lab-based evaluation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lab-based evaluation and treatment of OSA
Trial: 9564987
Drug: Salbutamol/nedocromil combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol/nedocromil combination (200 microg/4 mg)
Trial: 30265816
Drug: Fluticasone Furoate/Umeclidinium/Vilanterol
RxNorm normalized name: Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) 100 µg/62.5 µg/25 µg
Trial: 30265816
Drug: Budesonide/Formoterol (BUD/FOR)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/Formoterol (BUD/FOR) 400 µg/12 µg
Trial: 24841018
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of pre-operative antibiotics
Trial: 9000193
Drug: Standard-dose polyagent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose polyagent self‐administered intracavernous pharmacotherapy
Trial: 9000193
Drug: High-dose polyagent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose polyagent self‐administered intracavernous pharmacotherapy
Trial: 29133566
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg iclaprim administered as a 2-h infusion every 12 h
Trial: 29133566
Drug: 0.8 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg/kg iclaprim infused intravenously over 0.5 h every 12 h (previous regimen)
Trial: 23149085
Drug: Gastroretentive gabapentin
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gastroretentive gabapentin (G‐GR) 1800mg
Trial: 20494655
Drug: Intracoronary delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary delivery of abciximab (0.25 mg/kg)
Trial: 20494655
Drug: Intravenous delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous delivery of abciximab (0.25 mg/kg)
Trial: 20494655
Drug: High-dose abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose abciximab (>=0.30 mg/kg)
Trial: 20494655
Drug: Standard-dose abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose abciximab (0.25 mg/kg)
Trial: 20494655
Drug: High-dose abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose abciximab
Trial: 15689724
Drug: Skills-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skills-based treatment protocol
Trial: 15689724
Drug: Supportive relationship
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive relationship therapy
Trial: 2052467
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg daily plus hydrochlorothiazide 25 mg daily
Trial: 6137785
Drug: Lormetazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lormetazepam (0.5 mg)
Trial: 30975106
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (high intervention dose)
Trial: 25293966
Drug: Metacognitive detached
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metacognitive detached mindfulness therapy
Trial: 25058771
Drug: Lichtenstein technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lichtenstein technique (group L)
Trial: 15665959
Drug: Refracterin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refracterin therapy
Trial: 9129897
Drug: Intravenous digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous digoxin (mean dose 0.88 ± 0.35 mg)
Trial: 9129897
Drug: Placebo (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (mean dose 0.96 ± 0.37 mg)
Trial: 8186114
Drug: Calcipotriol solution
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol solution (50 micrograms/ml), applied twice daily for 4 weeks
Trial: 8186114
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle solution), applied twice daily for 4 weeks
Trial: 8186114
Drug: Calcipotriol solution
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol solution
Trial: 8186114
Drug: Calcipotriol solution
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol solution and Placebo
Trial: 25291974
Drug: sifuvirtide 10
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sifuvirtide 10 mg q.d. for 28 days
Trial: 25291974
Drug: sifuvirtide 20
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sifuvirtide 20 mg q.d. for 28 days
Trial: 25291974
Drug: sifuvirtide 20
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sifuvirtide 20 mg q.d. in combination with HAART for 168 days
Trial: 25291974
Drug: sifuvirtide (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sifuvirtide (both doses)
Trial: 21902704
Drug: Novafen (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novafen (325 mg paracetamol, 200 mg ibuprofen, 40 mg caffeine anhydrous)
Trial: 18814935
Drug: Diphenhydramine 25
RxNorm normalized name: DIPHENHYDRAMINE 25MG CHEW TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 25 mg with metoclopramide 10 mg
Trial: 18814935
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with metoclopramide 10 mg
Trial: 18814935
Drug: Diphenhydramine 25
RxNorm normalized name: DIPHENHYDRAMINE 25MG CHEW TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 25 mg with metoclopramide 20 mg
Trial: 18814935
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with metoclopramide 20 mg
Trial: 17437152
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (50 mg/kg in 100 ml of saline, followed by 8 mg/kg/h infusion)
Trial: 17437152
Drug: Saline (equal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (equal volume before induction and 8 mg/kg/h infusion)
Trial: 9777792
Drug: Tazarotene plus
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene plus placebo cream
Trial: 900433
Drug: Propanidid (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propanidid (7 mg/kg)
Trial: 900433
Drug: Etomidate with
RxNorm normalized name: Etomidate
DrugBank: Etomidate (DB00292)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etomidate with faster injection rate (15 seconds)
Trial: 27837201
Drug: 0.1% sirolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% sirolimus gel (adults)
Trial: 27837201
Drug: 0.05% sirolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% sirolimus gel (adults)
Trial: 25754396
Drug: Ertugliflozin 1
RxNorm normalized name: ertugliflozin 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 1 mg
Trial: 25754396
Drug: Ertugliflozin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 25 mg
Trial: 17724727
Drug: apical‐rectal blockade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apical‐rectal blockade
Trial: 15121563
Drug: Desogestrel pills
RxNorm normalized name: desogestrel Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel pills
Trial: 913230
Drug: Butaclamol (BT)
RxNorm normalized name: BTS
DrugBank: Pyruvic acid (DB00119)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butaclamol (BT) 10 mg
Trial: 913230
Drug: Butaclamol (BT)
RxNorm normalized name: BTS
DrugBank: Pyruvic acid (DB00119)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butaclamol (BT) 20 mg
Trial: 913230
Drug: Butaclamol (BT)
RxNorm normalized name: BTS
DrugBank: Pyruvic acid (DB00119)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butaclamol (BT) 40 mg
Trial: 30734717
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid at a daily dose of 500 mg
Trial: 30734717
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid at a daily dose of 750 mg
Trial: 30734717
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid at a daily dose of 1,000 mg
Trial: 30734717
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid at a daily dose of 1,500 mg
Trial: 24921623
Drug: Spinach supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinach supplementation (1 g/kg body weight daily for 14 days)
Trial: 6662170
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg of long acting (L.A.) propranolol
Trial: 6662170
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of sustained action (S.A.) metoprolol
Trial: 28240186
Drug: Tender coconut
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tender coconut water (TCW) 300 ml twice daily for 14 days
Trial: 28240186
Drug: Water 300
RxNorm normalized name: clindamycin phosphate/dextrose 5 % in water 300 mg/50 mL INTRAVEN IV SOLUTION, PIGGYBACK, BOTTLE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water 300 ml twice daily for 14 days
Trial: 11263780
Drug: High-dose penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose penicillamine
Trial: 11083272
Drug: Low-dose penicillamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose penicillamine
Trial: 6398982
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (21 g per day, taken with meals three times a day)
Trial: 25345628
Drug: Perampanel (PER)
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel (PER) 4 mg/day
Trial: 25345628
Drug: Perampanel (PER)
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel (PER) 8 mg/day
Trial: 25345628
Drug: Perampanel (PER)
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel (PER) 12 mg/day
Trial: 25345628
Drug: Perampanel (PER)
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel (PER) long-term treatment (10 or 12 mg/day)
Trial: 25345628
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events (AEs) with any dose of PER
Trial: 16599033
Drug: Metoclopramide 0.1‐0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 0.1‐0.2 mg kg(‐1)
Trial: 16599033
Drug: Prochlorperazine 0.1‐0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine 0.1‐0.2 mg kg(‐1)
Trial: 9929022
Drug: L-NMMA (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (6 mg/kg intravenous infusion)
Trial: 7478254
Drug: Tetrahydroaminoacridine (THA)
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine (THA) 75 mg
Trial: 7478254
Drug: Tetrahydroaminoacridine (THA)
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine (THA) 25 mg
Trial: 7478254
Drug: Tetrahydroaminoacridine (THA)
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine (THA) 25 or 75 mg
Trial: 2123433
Drug: Cerebrolysin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin plus multi-vitamins infusions
Trial: 28081673
Drug: lopinavir/ritonavir plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir plus lamivudine (dual therapy)
Trial: 28081673
Drug: lopinavir/ritonavir plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir plus 2 NRTI (triple therapy)
Trial: 15547020
Drug: Nicorandil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (20 mg twice daily)
Trial: 9424198
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of phytoadaptogen (Adapt)
Trial: 8221501
Drug: Meeting a
RxNorm normalized name: Dolce and Gabbana Meet Your Flawless Matte Skin Duo KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meeting a person with AIDS in the classroom (treatment group)
Trial: 31580698
Drug: Resistive Tecar
RxNorm normalized name: Tecartus
DrugBank: Brexucabtagene autoleucel (DB15699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistive Tecar Therapy (TT)
Trial: 31580698
Drug: Capacitive Tecar
RxNorm normalized name: Tecartus
DrugBank: Brexucabtagene autoleucel (DB15699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capacitive Tecar Therapy (TT)
Trial: 18925430
Drug: Recombinant HCG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant HCG (rHCG) - 250 microg subcutaneous injection
Trial: 18925430
Drug: Urinary HCG
RxNorm normalized name: Urinary hCG
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary HCG (uHCG) - 10,000 IU intramuscular injection
Trial: 15672335
Drug: 0.10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.10 mg/kg morphine IV bolus
Trial: 8759532
Drug: Otovent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otovent treatment set
Trial: 2012010
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg palmvitee capsules/day
Trial: 2012010
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg gamma-tocotrienol/d
Trial: 2012010
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg corn oil/d
Trial: 7356903
Drug: Cimetidine treatment
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine treatment
Trial: 29289383
Drug: HBsAg-1018 (HEPLISAV-B™)
RxNorm normalized name: HBSAG
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBsAg-1018 (HEPLISAV-B™) administered intramuscularly at weeks 0 and 4
Trial: 29289383
Drug: HBsAg-Eng (Engerix-B®)
RxNorm normalized name: HBSAG
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBsAg-Eng (Engerix-B®) administered at weeks 0, 4, and 24
Trial: 26968277
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (5.6 g/day)
Trial: 26968277
Drug: Oral paraffin
RxNorm normalized name: Paraffin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paraffin (placebo)
Trial: 22228325
Drug: Tracheal/esophageal traction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tracheal/esophageal traction exercise (TTE) treatment for 3 consecutive days before surgery
Trial: 22228325
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no TTE treatment)
Trial: 19306024
Drug: Myrtle oral
RxNorm normalized name: myrtle leaf oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myrtle oral paste applied four times a day for 6 days
Trial: 18366729
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) in combination with medication
Trial: 18366729
Drug: Usual secondary
RxNorm normalized name: Secondary potassium phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual secondary care in combination with medication
Trial: 16113617
Drug: TAU SSRI
RxNorm normalized name: Interferon tau
DrugBank: Interferon tau (DB16972)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAU SSRI plus brief cognitive-behavioral therapy (CBT) (n = 77)
Trial: 16113617
Drug: Treatment-as-usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (TAU) control condition (n = 75)
Trial: 12455393
Drug: Mycobacterium w
RxNorm normalized name: Mycobacterium W Vaccine
DrugBank: Mycobacterium w. Vaccine (DB15798)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mycobacterium w plus two antiretroviral agents
Trial: 2029855
Drug: Transcranial electric
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transcranial electric treatment (TET) with constant current and pulse current of square impulses of 70-80 Hz
Trial: 7332089
Drug: Tramadol-HCl continuous
RxNorm normalized name: Tramadol Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol-HCl continuous infusion
Trial: 30124459
Drug: Robot-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted therapy (30 min per session, 5 sessions per week for 8 weeks)
Trial: 30124459
Drug: General occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General occupational therapy (30 min per session, 5 sessions per week for 8 weeks)
Trial: 26914592
Drug: CPAP usage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP usage for <4 hours per night or no treatment
Trial: 9596431
Drug: Nebulized glucagon
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized glucagon (2 mg)
Trial: 3042994
Drug: Intravenous regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous regular insulin (0.0, 0.5, 1.0, 2.0, 3.0, and 4.0 units)
Trial: 3042994
Drug: Intravenous regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous regular insulin (various doses)
Trial: 26349115
Drug: Garenoxacin 200
RxNorm normalized name: Garénoxacine
DrugBank: Garenoxacin (DB06160)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Garenoxacin 200 mg
Trial: 26349115
Drug: Garenoxacin 400
RxNorm normalized name: Garénoxacine
DrugBank: Garenoxacin (DB06160)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Garenoxacin 400 mg
Trial: 23131836
Drug: Video-assisted swallowing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video-assisted swallowing therapy (VAST)
Trial: 21905793
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no hemostatic agents)
Trial: 8225637
Drug: Clarithromycin (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (125 mg for <25 kg or 250 mg for >25 kg, twice daily for 5 days)